|
|
axonogenesis
|
GO:0007409 |
274 |
0.575
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.392
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.382
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.361
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.319
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.286
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.280
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.278
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.251
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.247
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.231
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.219
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.215
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.207
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.206
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.206
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.202
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.193
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.182
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.174
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.170
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.168
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.166
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.163
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.159
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.159
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.158
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.155
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.153
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.153
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.151
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.147
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.147
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.142
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.142
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.142
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.140
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.137
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.135
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.134
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.130
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.129
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.129
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.128
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.126
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.126
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.124
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.124
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.122
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.121
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.120
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.118
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.116
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.115
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.115
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.112
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.111
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.107
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.106
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.106
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.104
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.104
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.103
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.101
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.100
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.100
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.099
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.098
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.098
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.097
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.095
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.095
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.095
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.094
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.092
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.092
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.091
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.090
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.090
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.090
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.090
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.089
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.088
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.088
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.087
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.087
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.087
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.086
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.085
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.085
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.085
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.084
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.083
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.083
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.082
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.082
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.082
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.082
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.082
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.082
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.081
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.081
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.081
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.081
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.081
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.081
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.080
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.079
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.079
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.079
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.078
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.078
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.078
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.077
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.077
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.076
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.076
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.075
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.074
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.074
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.074
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.073
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.070
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.070
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.070
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.070
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.069
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.069
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.068
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.068
|
|
|
|
metanephric capsule morphogenesis
|
GO:0072265 |
1 |
0.067
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.067
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.066
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.066
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.065
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.065
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.064
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.064
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.063
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.063
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.063
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.062
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.062
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.062
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.061
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.061
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.060
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.060
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.060
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.060
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.060
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.060
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.059
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.059
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.059
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.058
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.058
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.058
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.058
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.058
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.058
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.057
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.057
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.057
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.056
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.056
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.056
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.056
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.056
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.056
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.056
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.056
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.056
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.055
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.055
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.055
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.055
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.055
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.055
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.054
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.054
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.054
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.054
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.054
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.053
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.053
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.053
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.053
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.053
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.053
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.053
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.052
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.051
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.051
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.050
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.050
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.050
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.050
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.050
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.050
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.050
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.049
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.049
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.049
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.049
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.049
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.049
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.048
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.048
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.048
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.048
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.048
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.048
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.047
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.047
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.047
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.047
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.047
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.046
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.046
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.046
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.046
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.046
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.046
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.045
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.045
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.045
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.045
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.044
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.044
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.044
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.044
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.044
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.044
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.044
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.044
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.044
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.044
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.043
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.043
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.043
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.043
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.043
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.043
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.043
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.042
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.042
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.042
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.042
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.042
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.042
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.042
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.042
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.042
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.042
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.042
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.042
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.041
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.041
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.041
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.041
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.041
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.041
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.041
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.041
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.041
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.041
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.040
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.040
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.040
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.040
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.040
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.040
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.040
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.040
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.039
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.039
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.039
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.039
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.039
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.039
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.039
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.039
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.038
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.038
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.038
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.038
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.038
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.038
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.038
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.038
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.038
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.038
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.037
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.037
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.037
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.037
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.037
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.037
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.037
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.037
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.036
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.036
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.036
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.036
|
|
|
|
renal capsule formation
|
GO:0072129 |
1 |
0.036
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.036
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.036
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.036
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.035
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.035
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.035
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.035
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.035
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.035
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.035
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.034
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.034
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.034
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.034
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.034
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.034
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.034
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.034
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.034
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.034
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.034
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.034
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.034
|
|
|
|
renal capsule development
|
GO:0072127 |
1 |
0.034
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.033
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.033
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.033
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.033
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.033
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.033
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.033
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.033
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.033
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.033
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.032
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.032
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.032
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.032
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.032
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.032
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.032
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.032
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.032
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.032
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.032
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.032
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.032
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.032
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.031
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.031
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.031
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.031
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.031
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.031
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.031
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.031
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.031
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.031
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.031
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.031
|
|
|
|
paraxial mesoderm morphogenesis
|
GO:0048340 |
10 |
0.031
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.031
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.031
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.031
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.031
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.031
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.031
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.031
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.031
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.030
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.030
|
|
|
|
middle ear morphogenesis
|
GO:0042474 |
23 |
0.030
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.030
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.030
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.030
|
|
|
|
metanephric capsule development
|
GO:0072213 |
1 |
0.030
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.030
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.030
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.030
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.029
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.029
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.029
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.029
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.029
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.029
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.029
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.029
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.029
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.029
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.029
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.029
|
|
|
|
apoptotic process involved in outflow tract morphogenesis
|
GO:0003275 |
2 |
0.029
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.028
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.028
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.028
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.028
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.028
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.028
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.028
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.028
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.028
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.028
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.028
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.028
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.028
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.028
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.028
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.028
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.028
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.028
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.027
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.027
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.027
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.027
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.027
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.027
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.027
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.027
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.026
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.026
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.026
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.026
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.026
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.026
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.026
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.026
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.026
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.026
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.026
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.026
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.026
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.026
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.026
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.026
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.026
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.026
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.025
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.025
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.025
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.025
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.025
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.025
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.025
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.025
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.025
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.025
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.025
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.024
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.024
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.024
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.024
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.024
|
|